Literature DB >> 7384332

Neurotic illness and its response to anxiolytic and antidepressant treatment.

E C Johnstone, D G Owens, C D Frith, K McPherson, C Dowie, G Riley, A Gold.   

Abstract

Two hundred and forty neurotic out-patients were allocated to no diagnostic category but were rated in terms of observer and self ratings of both depression and anxiety at weekly intervals during a 4-week trial of amitriptyline, diazepam, amitriptyline and diazepam, and placebo. The sample could not be divided into anxious and depressed groups on the basis of the clinical picture. The outcome tended to be good irrespective of medication but the significant drug effects found were due to amitriptyline and concerned measures of anxiety as well as depression. It is concluded that a distinction between anxiety and depression in neurotic out-patients is of no practical value with regard to drug treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7384332     DOI: 10.1017/s0033291700044081

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  21 in total

1.  Benzodiazepines: time to withdraw.

Authors:  S A Montgomery; P J Tyrer
Journal:  J R Coll Gen Pract       Date:  1988-04

2.  The use of benzodiazepines in depression.

Authors:  D A Johnson
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

3.  Effective stress management.

Authors:  R France
Journal:  Occas Pap R Coll Gen Pract       Date:  1993-08

4.  Mixed Anxiety and Depression : Diagnosis and Treatment Options.

Authors:  D Bakish; R Habib; C L Hooper
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 5.  Relationship of anxiety and depression.

Authors:  A Frances; D Manning; D Marin; J Kocsis; K McKinney; W Hall; M Kline
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.

Authors:  H Giedke; H Gaertner; U Breyer-Pfaff; W Rein; D Axmann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

7.  Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin.

Authors:  J M da Roza Davis; A L Sharpley; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Is there seasonal variation in the prescribing of antidepressants in the community?

Authors:  K Skegg; D C Skegg; B W McDonald
Journal:  J Epidemiol Community Health       Date:  1986-12       Impact factor: 3.710

9.  Effects of ritanserin on aversive classical conditioning in humans.

Authors:  R Hensman; F S Guimarães; M Wang; J F Deakin
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Observer bias in the assessment of anxiety and depression.

Authors:  G Lewis
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1991-12       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.